| 4Q26 |
$230.405 |
+$62.038 |
0.3 ML |
SARSCV2 VAC 30MCG TRS-SUC IM |
v1, posted September 17, 2026 |
| 3Q26 |
$168.367 |
$0.00 |
0.3 ML |
SARSCV2 VAC 30MCG TRS-SUC IM |
v1, posted September 15, 2026 |
| 2Q26 |
$168.367 |
$0.00 |
0.3 ML |
SARSCV2 VAC 30MCG TRS-SUC IM |
v1, posted September 15, 2026 |
| 1Q26 |
$168.367 |
$0.00 |
0.3 ML |
SARSCV2 VAC 30MCG TRS-SUC IM |
v1, posted September 15, 2026 |
| 4Q25 |
$168.367 |
+$12.472 |
0.3 ML |
SARSCV2 VAC 30MCG TRS-SUC IM |
v1, posted September 8, 2026 |
| 3Q25 |
$155.895 |
$0.00 |
0.3 ML |
SARSCV2 VAC 30MCG TRS-SUC IM |
v1, posted March 10, 2026 |
| 2Q25 |
$155.895 |
$0.00 |
0.3 ML |
SARSCV2 VAC 30MCG TRS-SUC IM |
v1, posted March 10, 2026 |
| 1Q25 |
$155.895 |
$0.00 |
0.3 ML |
SARSCV2 VAC 30MCG TRS-SUC IM |
v1, posted December 19, 2025 |
| 4Q24 |
$155.895 |
+$24.795 |
0.3 ML |
SARSCV2 VAC 30MCG TRS-SUC IM |
v1, posted June 11, 2025 |
| 3Q24 |
$131.10 |
$0.00 |
0.3 ML |
SARSCV2 VAC 30MCG TRS-SUC IM |
v1, posted June 11, 2025 |
| 2Q24 |
$131.10 |
$0.00 |
0.3 ML |
SARSCV2 VAC 30MCG TRS-SUC IM |
v1, posted March 11, 2025 |
| 1Q24 |
$131.10 |
$0.00 |
0.3 ML |
SARSCV2 VAC 30MCG TRS-SUC IM |
v1, posted December 19, 2024 |
| 4Q23 |
$131.10 |
– |
0.3 ML |
SARSCV2 VAC 30MCG TRS-SUC IM |
v1, posted October 10, 2024 |